Medtronic PLC Ownership
| MDT Stock | USD 86.21 1.47 1.73% |
Shares in Circulation | First Issued 1985-12-31 | Previous Quarter 1.3 B | Current Value 1.3 B | Avarage Shares Outstanding 1.1 B | Quarterly Volatility 200.8 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Medtronic |
Medtronic Stock Ownership Analysis
About 85.0% of the company shares are owned by institutional investors. The book value of Medtronic PLC was now reported as 38.29. The company has Price/Earnings To Growth (PEG) ratio of 1.6. Medtronic PLC last dividend was issued on the 27th of September 2024. The entity had 2:1 split on the 27th of September 1999. Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The company was founded in 1949 and is headquartered in Dublin, Ireland. Medtronic operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 95000 people. To find out more about Medtronic PLC contact Omar Ishrak at 353 1 438 1700 or learn more at https://www.medtronic.com.Besides selling stocks to institutional investors, Medtronic PLC also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Medtronic PLC's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Medtronic PLC's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Medtronic PLC Quarterly Liabilities And Stockholders Equity |
|
Medtronic PLC Insider Trades History
Less than 1% of Medtronic PLC are currently held by insiders. Unlike Medtronic PLC's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Medtronic PLC's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Medtronic PLC's insider trades
Medtronic Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Medtronic PLC is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Medtronic PLC backward and forwards among themselves. Medtronic PLC's institutional investor refers to the entity that pools money to purchase Medtronic PLC's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Deutsche Bank Ag | 2024-06-30 | 16.7 M | Franklin Resources Inc | 2024-09-30 | 16.6 M | Norges Bank | 2024-06-30 | 15.6 M | Legal & General Group Plc | 2024-06-30 | 11.6 M | Royal Bank Of Canada | 2024-06-30 | 11.4 M | Northern Trust Corp | 2024-09-30 | 11.4 M | Ameriprise Financial Inc | 2024-06-30 | 10.9 M | Amvescap Plc. | 2024-06-30 | 10.8 M | Alliancebernstein L.p. | 2024-06-30 | 10.7 M | Vanguard Group Inc | 2024-09-30 | 123.4 M | Blackrock Inc | 2024-06-30 | 111.9 M |
Medtronic PLC Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Medtronic PLC insiders, such as employees or executives, is commonly permitted as long as it does not rely on Medtronic PLC's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Medtronic PLC insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Medtronic PLC's latest congressional trading
Congressional trading in companies like Medtronic PLC, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Medtronic PLC by those in governmental positions are based on the same information available to the general public.
| 2024-09-12 | Senator Tommy Tuberville | Acquired $15K to $50K | Verify | ||
| 2024-09-02 | Representative John James | Acquired Under $15K | Verify | ||
| 2024-08-21 | Representative Jared Moskowitz | Acquired Under $15K | Verify | ||
| 2024-08-16 | Representative Kathy Manning | Acquired Under $15K | Verify | ||
| 2024-08-06 | Representative Earl Blumenauer | Acquired Under $15K | Verify | ||
| 2024-03-15 | Senator Shelley Moore Capito | Acquired Under $15K | Verify | ||
| 2024-03-14 | Senator Shelley Moore Capito | Acquired Under $15K | Verify | ||
| 2023-12-14 | Representative Debbie Dingell | Acquired $15K to $50K | Verify | ||
| 2023-10-20 | Senator Pete Ricketts | Acquired $50K to $100K | Verify | ||
| 2023-04-19 | Senator Tina Smith | Acquired $100K to $250K | Verify | ||
| 2023-04-18 | Senator Tina Smith | Acquired $100K to $250K | Verify | ||
| 2022-08-07 | Representative Alan S Lowenthal | Acquired Under $15K | Verify | ||
| 2022-08-04 | Representative Alan S Lowenthal | Acquired Under $15K | Verify | ||
| 2022-06-12 | Senator Roy Blunt | Acquired $15K to $50K | Verify | ||
| 2016-10-04 | Senator Thomas R Carper | Acquired Under $15K | Verify | ||
| 2016-10-03 | Senator Thomas R Carper | Acquired Under $15K | Verify | ||
| 2015-02-25 | Senator Gary Peters | Acquired $15K to $50K | Verify | ||
| 2015-02-24 | Senator Gary Peters | Acquired $15K to $50K | Verify |
Medtronic PLC Outstanding Bonds
Medtronic PLC issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Medtronic PLC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Medtronic bonds can be classified according to their maturity, which is the date when Medtronic PLC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Medtronic PLC Corporate Filings
8K | 19th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 24th of October 2024 Other Reports | ViewVerify | |
| 5th of September 2024 Other Reports | ViewVerify | |
10Q | 27th of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medtronic Stock Analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.